HIGHLIGHTS
- who: Melania Tesio from the (UNIVERSITY) have published the paper: Novel Targeted Therapies for T-Cell Malignancies, in the Journal: Cancers 2022, 14, 3955. of 13/07/2022
SUMMARY
This group is broadly divided into two categories, namely peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphomas (CTCL), which is characterized by malignant T-cells infiltrating the skin. The heterogeneity of T-cell malignancies, which parallels the heterogeneity in the T-cell maturation stage, functions and tissue-specific distribution, reflects prognostic differences. With the exception of ALK-positive anaplastic large-cell lymphoma . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.